Home Mobile games Living community 5G technology Commercial street Fashion icon More

Yiling Pharmaceutical Lianhua Qingwen capsules help to prevent and control the global epidemic

2020-04-11

On April 9, Shijiazhuang Yiling Pharmaceutical Co., Ltd donated 2 million yuan to the Red Cross foundation of China to be used in the international humanitarian assistance fund to support the prevention and control of the international epidemic. After the outbreak of the new epidemic, Yiling Pharmaceutical took the lead in donating Lianhua Qingwen capsules which worth more than 10 million yuan to support the prevention and control of the domestic epidemic. After the situation of overseas epidemic prevention and control intensified, Yiling Pharmaceutical actively supported the international epidemic prevention and control. On March 12, 2016, it donated 1.8944 million yuan and 1.48 million Lianhua Qingwen capsules to the Red Cross society of China to support the epidemic prevention and control in Iraq and Italy.

Wu Xiangjun, general manager of Yiling Pharmaceutical co., LTD., introduced that the company's patented traditional Chinese medicine, Lianhua Qingwen capsules (granules), has been recommended by the national and more than 20 provinces and cities for the treatment of covid-19. It has become the most frequently recommended Chinese patent medicine and is widely used in medical institutions.

Cao Xuejun, deputy director of the consumer goods industry department of the ministry of industry and information technology, said that drugs are the important material basis and the guarantee for the prevention and control of the epidemic at a press conference on April 8.

After the relevant drugs were included in the medical plan, the enterprise has been producing at full capacity, with sufficient inventory and guaranteed market supply. Up to now, the daily production capacity of Lianhua Qingwen capsules has reached 2 million boxes and the inventory is 30 million boxes.

In the battle against epidemic diseases, traditional Chinese medicine has been rarely seen in its wide participation, deep participation and high attention. The role of traditional Chinese medicine is fully reflected in the whole process of prevention, treatment and rehabilitation.

Before this, Lianhua Qingwen has been already exported to Canada, Romania, Thailand, Mozambique, Brazil, Indonesia and China Hong Kong, Macao. Since the end of February, the company has received orders from overseas, and the demand for drugs has been rising rapidly. Chinese traditional medicine began to go abroad and was recognized by the international community.



Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

Jewellery & Gem ASEAN Bangkok (JGAB) 2025: Connecting ASEAN's Gem and Jewellery Business to the Global Market

BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors

Acer Reports FY2024 Net Income of NT$5.54 Billion and NT$1.7 Cash Dividend Per Share

Ping An #1 in Brand Finance's Global Insurance Brand Value for 9th Year, Brand Value Reaches $33.6 Billion

LITEON Showcase Groundbreaking Energy Savings in Private 5G Network with NTT EAST at MWC 2025

2025 Global Sources Hong Kong Shows: Shaping the Future of Consumer Trends and Redefining Sourcing

©Copyright 2009-2020 Startup Weekly    Contact Us  SiteMap